Clinakos

News Events & Articles

JP Morgan, Clinakos, Patient Data, Pharmaceutical, AI, ML

Meet us at JPMorgan Chase & Co.’s 41st Annual JP Morgan Healthcare Conference

Meet us at JPMorgan Chase & Co.’s 41st Annual JP Morgan Healthcare Conference January 10, 2023 Meet Clinakos Inc. at JPMorgan Chase & Co.‘s 41st Annual JP Morgan Healthcare Conference in San Francisco. Our team is here till Thursday Jan 12th meeting with clients, partners and anyone else who shares our vision of democratizing patient […]

Meet us at JPMorgan Chase & Co.’s 41st Annual JP Morgan Healthcare Conference Read More »

Clinakos Spreads Breast Cancer Awareness day

Clinakos Spreads Breast Cancer Awareness day October 13, 2022 Over 300 million people worldwide are affected by rare diseases. Rare diseases impact the lives of people of all races, religions, and socio-economic status. Clinakos is proud to support the Rare Disease Patients and Life science partners in developing and commercializing cures via our unique data

Clinakos Spreads Breast Cancer Awareness day Read More »

Clinakos is proud to enable Patient Level Data for our large and small pharma clients

Clinakos is proud to enable Patient Level Data for our large and small pharma clients September 6, 2022 Patient Level Data especially in oncology and rare diseases provides a unique opportunity for pharmaceutical franchise leaders and launch teams. Access to hard-to-find patient populations tying qualitative and quantitative research to real-time linked patient-level medical records including

Clinakos is proud to enable Patient Level Data for our large and small pharma clients Read More »

Clinakos Inc. partners with Rare Patient Voice to provide unique offering

Clinakos Inc. partners with Rare Patient Voice to provide unique offering August 24, 2022 Clinakos Inc. is extremely proud to share our capabilities with Wes Michael and his team at Rare Patient Voice to provide this one of kind offering for our pharmaceutical and biotech clients. Back to News, Events & Articles

Clinakos Inc. partners with Rare Patient Voice to provide unique offering Read More »

The Power of Patient Data: New Opportunities for Lifesciences

The Power of Patient Data: New Opportunities for Lifesciences September 14, 2023 Over 2,100 registrants signed up to learn how patient data is disrupting life sciences product development and commercialization. The recording of THE POWER OF PATIENT DATA: New Opportunities for Life Sciences from Rare Patient Voice and Clinakos is is now available on LinkedIn

The Power of Patient Data: New Opportunities for Lifesciences Read More »

Clinakos, CDISC2021, RWE, RWE, Drug Development, Pharmaceutical company

Clinakos CEO to present at CDISC 2021 US Interchange on October 20, 2021

Clinakos CEO to present at CDISC 2021 US Interchange on October 20, 2021 September 23, 2021 Clinakos CEO Inder Jaggi has been invited to present at CDISC’s 2021 US Interchange conference. The title of his talk is “Impact of HHS Final Data Blocking Rule on RWD/RWE Generation.” This talk describes the increasingly important role of

Clinakos CEO to present at CDISC 2021 US Interchange on October 20, 2021 Read More »

Webinar Replay: Combining Patient Data with the Patient Voice: A Novel Approach

Webinar Replay: Combining Patient Data with the Patient Voice: A Novel Approach September 15, 2021 https://player.vimeo.com/video/605776707?dnt=1&app_id=122963&h=c95704dd1dClinakos and Rare Patient Voice’s webinar was one of Pharmavoice’s most attended webinars of the year. This webinar covered recent technological and regulatory changes that have enabled a novel approach to combing real world data with market research. Combining the

Webinar Replay: Combining Patient Data with the Patient Voice: A Novel Approach Read More »

Scroll to Top

Connect with us